Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2018 R21 RFA-CA-17-010 ROYZEN, MAKSIM STATE UNIVERSITY OF NEW YORK AT ALBANY Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies Active
2021 R21 RFA-CA-20-017 XIAO, HAN RICE UNIVERSITY Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion Active
2020 R33 RFA-CA-19-020 RECHT, MICHAEL PALO ALTO RESEARCH CENTER High-Throughput Screening Platform for Cancer Drug Discovery Active
2019 R21 RFA-CA-18-002 WU, YUN STATE UNIVERSITY OF NEW YORK AT BUFFALO Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Active
2021 R21 RFA-CA-20-017 SWAGER, TIMOTHY M MASSACHUSETTS INSTITUTE OF TECHNOLOGY Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation Active
2020 R33 RFA-CA-19-020 LEVINSON, NICHOLAS MARK UNIVERSITY OF MINNESOTA Time-resolved FRET-based allostery sensors for any protein kinase drug target Active
2019 R21 RFA-CA-18-002 ZHU, YAZHEN UNIVERSITY OF CALIFORNIA LOS ANGELES Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs Active
2018 R21 RFA-CA-17-010 SHI, TUJIN BATTELLE PACIFIC NORTHWEST LABORATORIES An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells Active
2021 R21 RFA-CA-20-017 BAR-PELED, LIRON MASSACHUSETTS GENERAL HOSPITAL Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors Active
2020 R33 RFA-CA-19-020 CHEN, FEI BROAD INSTITUTE, INC. Clinical implementations of spatial transcriptomics in tumors Active
2019 R21 RFA-CA-18-002 WEISSLEDER, RALPH MASSACHUSETTS GENERAL HOSPITAL Single Circulating Vesicle Analysis for Early Cancer Detection Active
2021 R21 RFA-CA-20-017 CHEN, KAI UNIVERSITY OF SOUTHERN CALIFORNIA Novel Bisphosphonate PET Probes for Myeloma Bone Disease Active
2020 R33 RFA-CA-19-020 FAN, RONG YALE UNIVERSITY High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer Active
2019 R21 RFA-CA-18-002 GARBER, MANUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER A modular; customizable sequencing system for simultaneous genotyping and transcript analysis in single cells Active
2022 R21 CA21-003 COUNTER, CHRISTOPHER M DUKE UNIVERSITY Adapting K-MDS to detect KRAS-mutant ctDNA Active
2021 R33 RFA-CA-20-018 JI, HANLEE P STANFORD UNIVERSITY Multimodal iterative sequencing of cancer genomes and single tumor cells Active
2020 R21 RFA-CA-19-021 SEIBEL, ERIC J UNIVERSITY OF WASHINGTON Rapid Needle Biopsy Assessment at Point of Care to advance personalized cancer therapy Active
2019 R21 RFA-CA-18-002 BHATNAGAR, PARIJAT SRI INTERNATIONAL T-cell Biofactories for targeting interstitial fluid pressure Active
2000 R21 PAR-99-100 HUNTER, IAN W MASSACHUSETTS INSTITUTE OF TECHNOLOGY ANDROGEN RECEPTOR BIOCHIPS--PROSTATE CANCER MANAGEMENT Complete
2002 R21 PAR-99-100 MAYER, BRUCE J UNIVERSITY OF CONNECTICUT SCH OF MED/DNT PROFILING TUMOR CELLS BY SH2 DOMAIN BINDING PATTERN Complete
2005 R21 RFA-CA-05-003 TEMPST, PAUL SLOAN-KETTERING INSTITUTE FOR CANCER RES PEPTIDE PROFILING TECHNIQUES TO DETECT THYROID CARCINOMA Complete
2008 R21 RFA-CA-07-033 JIN, SONG UNIVERSITY OF WISCONSIN-MADISON ULTRASENSITIVE NANOSCALE MAGNETIC SENSORS FOR LABEL-FREE ANALYSIS OF CANCER Complete
2011 R21 RFA-CA-10-005 MO, YIN-YUAN SOUTHERN ILLINOIS UNIVERSITY SCH OF MED METHODS OF SYSTEMATIC MICRORNA TARGET VALIDATION AND IDENTIFICATION Complete
2015 R21 RFA-CA-14-003 HAMMOND, SCOTT M UNIV OF NORTH CAROLINA CHAPEL HILL AN OPTIMIZED DESIGN FOR SINGLE COPY SHORT HAIRPIN RNAI Complete
1999 R41 PAR-98-066 MACH, ROBERT H ANASAZI BIOMEDICAL RESEARCH, INC. SIGMA 1 RECEPTOR PROBES FOR IMAGING TUMOR PROLIFERATION Complete
2001 R41 PAR-99-101 SULK, ROBERTA A DELTANU, LLC ONE STEP H. PYLORI TEST--SCREENING AND INDIVIDUAL ASSAYS Complete
2004 R33 PAR-01-106 VIDAL, MARC DANA-FARBER CANCER INSTITUTE INTEGRATED INTERACTOME MAPPING Complete
2007 R21 RFA-CA-07-019 KOPELMAN, RAOUL UNIVERSITY OF MICHIGAN NANOBIOPHOTONICS ENABLED TUMOR SURGERY AND INTRAOPERATIVE PDT Complete
2010 R21 RFA-CA-09-008 BURKE, PETER J. UNIVERSITY OF CALIFORNIA-IRVINE NANOELECTRODE ARRAYS FOR STUDY OF THE MOLECULAR MECHANISMS, TRIGGERS, AND INHIBIT Complete
2014 R21 RFA-CA-13-003 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER MICROFLUIDIC APPROACH FOR THE DEVELOPMENT OF A THREE-DIMENSIONAL BONE MARROW MICR Complete
2001 R21 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
2003 R33 PAR-01-104 TAYLOR, CLIVE R UNIVERSITY OF SOUTHERN CALIFORNIA RETRIEVAL OF DNA, RNA, AND PROTEIN FROM ARCHIVAL TISSUE Complete
2006 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2009 R21 RFA-CA-08-009 DRAKE, RICHARD R. EASTERN VIRGINIA MEDICAL SCHOOL PROXIMAL PROSTATE FLUIDS FOR PROTEIN AND MIRNA BIOMARKERS Complete
2013 R21 RFA-CA-13-001 TAVANA, HOSSEIN UNIVERSITY OF AKRON A NOVEL HIGH THROUGHPUT TUMOR SPHEROID MICROTECHNOLOGY Complete
2016 R33 RFA-CA-15-005 JOHANN, DONALD UNIV OF ARKANSAS FOR MED SCIS DEVELOPMENT AND VALIDATION OF A MICRODISSECTION METHOD TO ADVANCE PRECISION MEDICINE IN THE CLINICAL SETTING Complete
2000 R33 PAR-99-100 WIGLER, MICHAEL H COLD SPRING HARBOR LABORATORY HIGH DENSITY GENE COPY NUMBER MICROARRAYS Complete
2002 R43 PAR-99-101 SHEFER, RUTH E NEWTON SCIENTIFIC, INC. A LASER-ACTIVATED REACTOR FOR BIOMEDICAL C-14-AMS Complete
2006 R21 RFA-CA-06-002 GHOSH, INDRANEEL UNIVERSITY OF ARIZONA DIRECT DETECTION OF HYPERMETHYLATION IN CANCER Complete
2008 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2012 R21 RFA-CA-12-002 STEINMAN, RICHARD A UNIVERSITY OF PITTSBURGH AT PITTSBURGH EXOSOMAL RECOMBINASE-A TOOL TO DISSECT METASTASIS AND THE CANCER MICROENVIRONMENT Complete
2015 R43 PAR-13-327 MCCONNELL, TIMOTHY S ISOPLEXIS, INC. A SINGLE CELL MULTI-PROTEIN DEVICE TO FACILITATE CANCER IMMUNOTHERAPY Complete
2015 R43 PAR-13-327 SARAF, RAVI VAJRA INSTRUMENTS, INC. PROFILING CIRCULATING MIRNA WITHOUT PCR FOR EARLY DETECTION OF PANCREATIC CANCER Complete
2000 R21 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2002 R21 PAR-99-100 CLEVELAND, WILLIAM L ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS ROBOTIC PREPARATION OF CDNA SINGLE CELLS Complete
2005 R21 RFA-CA-05-003 OLIVI, ALESSANDRO JOHNS HOPKINS UNIVERSITY "ENHANCEMENT OF BRAIN TUMOR IMMUNOTHERAPY BY FAS-L RNAI" Complete
2008 R21 RFA-CA-07-033 CHAPUT, JOHN CHARLES ARIZONA STATE UNIVERSITY-TEMPE CAMPUS A HIGH-THROUGHPUT ROUTE TO SYNTHETIC ANTIBODIES FOR ARRAY-BASED CANCER DETECTION Complete
2011 R21 RFA-CA-10-005 MESSMER, BRADLEY T UNIVERSITY OF CALIFORNIA SAN DIEGO MOLECULAR EVOLUTION OF MULTIFUNCTIONAL DNA NANOPARTICLES Complete
2015 R21 RFA-CA-14-003 PATTI, GARY JOSEPH WASHINGTON UNIVERSITY CELL-SPECIFIC ISOTOPE LABELING TO TRACK INTERCELLULAR METABOLITE EXCHANGE IN CANCER Complete
1999 R43 PAR-98-066 MOSTERT, MICHAEL J ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete

Pages